Mistletoe therapy, widely used in integrative oncology, has gained attention for its supportive role in cancer care. Derived from the European mistletoe plant (Viscum album), this therapy is often administered through subcutaneous injections to stimulate the immune system, improve quality of life, and reduce treatment-related fatigue. While many patients tolerate mistletoe therapy well, it is important to understand the possible side effects associated with its use.
Most side effects of mistletoe therapy are mild and temporary. The most common include redness, swelling, or itching at the injection site. These local reactions generally indicate the immune system’s response and often resolve without medical intervention. Some patients may also experience flu-like symptoms such as mild fever, fatigue, or muscle aches, which typically subside within a few days.
In rare cases, mistletoe therapy may cause stronger reactions such as high fever, chills, or allergic responses. Individuals with certain health conditions, such as autoimmune diseases, should use mistletoe therapy under strict medical supervision to avoid complications. Severe side effects are uncommon but must be carefully monitored by healthcare professionals.
Overall, mistletoe therapy is considered safe when prescribed and supervised by experienced practitioners. It is not a replacement for conventional cancer treatments but serves as a complementary approach to enhance well-being. Patients should always consult their oncologist before starting mistletoe therapy to ensure it is suitable for their specific health condition.
By understanding both its benefits and possible side effects, patients can make informed decisions about integrating mistletoe therapy into their cancer care journey.
